BioMed Research International / 2009 / Article / Tab 1

Research Article

Serodeconversion of HIV Antibody-Positive AIDS Patients Following Treatment with V-1 Immunitor

Table 1

Summary of lab tests on serodeconverted HIV-positive patients treated with V1.

No.GenderAgeHIV disease stage as per the WHO criteriaMonths since known as being infected as per patient's recollectionFirst tested positive (m/y)Months on V1HIV positive timesaHIV negative timesbHIV PCR copies beforecHIV PCR copies afterQualitative PCRd positiveQualitative PCRd negative

01F30413/001425617<502
02F3820.57/01224<501
03F313189/0144821
04F2441810/01411
05F27329/012411830
06M263Unknown4/01122<50
07F193Unknown6/01113
08M284156/0210171
09M32374/0015110127; 2710<400; <501
10F28378/013501140; 162011
11F294211/01870<50; <40022
12M244245/02113543900
13M283122/02914
14M304363/021013
15M4041203/021011
16M58461/02611
17M3220.512/010.511
18M384962/021113
19M434325/021114
20M333Unknown5/02311
21M24248/021512
22M24243/02213
23F294Unknown2/021311<400

aTests were done at baseline before treatment initiation.bTests were performed after treatment initiation.cTests were done after treatment initiation, not at baseline.dDue to high cost, some patients had qualitative PCR tests, that is, positive or negative, rather than quantitative ones—all of such tests were carried out after treatment initiation.

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.